aspirin has been researched along with Cancer of Gastrointestinal Tract in 49 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hepatocellular carcinoma is one of the most common malignant tumors in the digestive tract, so it is necessary to find effective preventive and therapeutic measures." | 6.66 | [Effect of aspirin on hepatocellular carcinoma and its related mechanism]. ( Liu, YW; Niu, JQ; Xu, HQ; Zhou, Q, 2020) |
| "Aspirin has been associated with a reduced risk of colorectal cancer, and possibly of a few other digestive tract cancers." | 5.05 | Aspirin and the risk of colorectal and other digestive tract cancers: an updated meta-analysis through 2019. ( Bosetti, C; Gallus, S; La Vecchia, C; Martinetti, M; Santucci, C, 2020) |
| "The US Preventive Services Task Force recently recommended the use of aspirin to prevent colorectal cancer and cardiovascular disease among many US adults." | 4.93 | Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer. ( Cao, Y; Chan, AT; Fuchs, CS; Giovannucci, EL; Nishihara, R; Ogino, S; Spiegelman, D; Wang, M; Willett, WC; Wu, K, 2016) |
| "In rodents, nonsteroidal anti-inflammatory drugs (NSAIDs) including aspirin inhibit chemically induced adenomas and early carcinomas of the colon." | 4.79 | Aspirin and gastrointestinal cancer. ( Thun, MJ, 1997) |
| "Current guidelines offer a choice of P2Y12 receptor antagonist among clopidogrel, prasugrel or ticagrelor on top of aspirin (ASA) for dual antiplatelet therapy (DAPT) in patients after acute coronary syndromes (ACS)." | 3.79 | Gastrointestinal adverse events after dual antiplatelet therapy: clopidogrel is safer than ticagrelor, but prasugrel data are lacking or inconclusive. ( Can, MM; Dinicolantonio, JJ; Kuliczkowski, W; Pershukov, IV; Serebruany, VL, 2013) |
| "Hepatocellular carcinoma is one of the most common malignant tumors in the digestive tract, so it is necessary to find effective preventive and therapeutic measures." | 2.66 | [Effect of aspirin on hepatocellular carcinoma and its related mechanism]. ( Liu, YW; Niu, JQ; Xu, HQ; Zhou, Q, 2020) |
| "Aspirin has been one of the most widely used medications since its first synthesis more than 100 years ago." | 2.52 | Aspirin Use on Incidence and Mortality of Gastrointestinal Cancers: Current State of Epidemiological Evidence. ( Huang, WK; See, LC; Tu, HT, 2015) |
| "Reduction in distant metastasis and improvements in cancer outcomes appear within 5 years of randomization indicating that aspirin affects tumour growth or the development and spread of metastases from existing cancers or both." | 2.50 | Aspirin in gastrointestinal oncology: new data on an old friend. ( Langley, RE; Rothwell, PM, 2014) |
| " Optimal chemoprevention requires long-term use and high dose of aspirin that may increase the risk of gastrointestinal bleeding." | 2.46 | Chemoprophylaxis in gastrointestinal tumors. ( Iacobelli, S; Zilli, M, 2010) |
| "Gastrointestinal cancers are among the leading sites of cancer and leading causes of cancer-related deaths." | 2.39 | Prevention of gastrointestinal cancer--the potential role of NSAIDs in colorectal cancer. ( Luk, GD, 1996) |
| "Aspirin was prescribed in a quarter of cases and controls, COX-2 inhibitors in 4% of cases and 5% of controls and other NSAIDs in 33% of cases and 36% of controls." | 1.40 | Aspirin and non-steroidal anti-inflammatory drug use and the risk of upper aerodigestive tract cancer. ( Lefevre, K; Macfarlane, TV; Watson, MC, 2014) |
| "Uninvestigated dyspepsia is common in family practice." | 1.32 | The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study. ( Armstrong, D; Barkun, AN; Chakraborty, B; Chiba, N; Daniels, S; Escobedo, S; Sinclair, P; Thomson, AB; Van Zanten, SJ; White, RJ, 2003) |
| "In the presence of a chronic consumption coagulopathy, it remains uncertain whether antiplatelet drugs are of prophylactic antithrombotic value." | 1.28 | Blue rubber-bleb naevus syndrome: report of a case with consumption coagulopathy complicated by manifest thrombosis. ( Bouquet, J; Hofhuis, WJ; Oranje, AP; Sinaasappel, M, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (6.12) | 18.7374 |
| 1990's | 6 (12.24) | 18.2507 |
| 2000's | 12 (24.49) | 29.6817 |
| 2010's | 20 (40.82) | 24.3611 |
| 2020's | 8 (16.33) | 2.80 |
| Authors | Studies |
|---|---|
| Shami, JJP | 1 |
| Zhao, J | 1 |
| Pathadka, S | 1 |
| Wan, EYF | 1 |
| Blais, JE | 1 |
| Vora, P | 1 |
| Soriano-Gabarró, M | 1 |
| Cheung, KS | 1 |
| Leung, WK | 1 |
| Wong, ICK | 1 |
| Chan, EW | 1 |
| Umar, A | 2 |
| Loomans-Kropp, HA | 2 |
| Patrono, C | 1 |
| Cavalcoli, F | 1 |
| Pusceddu, S | 1 |
| Zilli, A | 1 |
| Tamagno, G | 1 |
| Femia, D | 1 |
| Prinzi, N | 1 |
| Travers, J | 1 |
| Consonni, D | 1 |
| Ciafardini, C | 1 |
| Conte, D | 1 |
| Massironi, S | 1 |
| Xie, SH | 1 |
| Chen, R | 1 |
| Zhao, DL | 1 |
| Liu, YQ | 1 |
| Hao, CQ | 1 |
| Zhang, YZ | 1 |
| Song, GH | 1 |
| Hua, ZL | 1 |
| Wang, JL | 1 |
| Liu, SZ | 1 |
| Zhang, LW | 1 |
| Shao, DT | 1 |
| Qin, Y | 1 |
| Li, MJ | 1 |
| Zhou, JC | 1 |
| Zheng, RS | 1 |
| Wang, GQ | 1 |
| Wei, WW | 1 |
| Bosetti, C | 2 |
| Santucci, C | 2 |
| Gallus, S | 2 |
| Martinetti, M | 1 |
| La Vecchia, C | 2 |
| Jacobsen, AP | 1 |
| Khiew, YC | 1 |
| Blumenthal, RS | 1 |
| Martin, SS | 1 |
| Liu, YW | 1 |
| Xu, HQ | 1 |
| Zhou, Q | 1 |
| Niu, JQ | 1 |
| Ueki, N | 1 |
| Futagami, S | 1 |
| Akimoto, T | 1 |
| Maruki, Y | 1 |
| Yamawaki, H | 1 |
| Kodaka, Y | 1 |
| Nagoya, H | 1 |
| Shindo, T | 1 |
| Kusunoki, M | 1 |
| Kawagoe, T | 1 |
| Gudis, K | 1 |
| Miyake, K | 1 |
| Iwakiri, K | 1 |
| Wu, W | 1 |
| Chen, J | 1 |
| Ding, Q | 1 |
| Yang, D | 1 |
| Yu, H | 1 |
| Lin, J | 1 |
| Brusselaers, N | 1 |
| Lagergren, J | 1 |
| Shen, XN | 1 |
| Fang, JY | 1 |
| Serebruany, VL | 1 |
| Dinicolantonio, JJ | 1 |
| Can, MM | 1 |
| Pershukov, IV | 1 |
| Kuliczkowski, W | 1 |
| Langley, RE | 2 |
| Rothwell, PM | 1 |
| Macfarlane, TV | 1 |
| Lefevre, K | 1 |
| Watson, MC | 1 |
| Nelson, N | 1 |
| Huang, WK | 1 |
| Tu, HT | 1 |
| See, LC | 1 |
| Goldberg, RM | 1 |
| McBride, D | 1 |
| Vilar, E | 1 |
| Maresso, KC | 1 |
| Hawk, ET | 1 |
| Cao, Y | 1 |
| Nishihara, R | 1 |
| Wu, K | 1 |
| Wang, M | 1 |
| Ogino, S | 1 |
| Willett, WC | 1 |
| Spiegelman, D | 1 |
| Fuchs, CS | 1 |
| Giovannucci, EL | 1 |
| Chan, AT | 1 |
| Kataoka, Y | 1 |
| Tsuji, Y | 1 |
| Sakaguchi, Y | 1 |
| Minatsuki, C | 1 |
| Asada-Hirayama, I | 1 |
| Niimi, K | 1 |
| Ono, S | 1 |
| Kodashima, S | 1 |
| Yamamichi, N | 1 |
| Fujishiro, M | 1 |
| Koike, K | 1 |
| Frouws, MA | 1 |
| Bastiaannet, E | 1 |
| Chia, WK | 1 |
| van Herk-Sukel, MP | 1 |
| Lemmens, VE | 1 |
| Putter, H | 1 |
| Hartgrink, HH | 1 |
| Bonsing, BA | 1 |
| Van de Velde, CJ | 1 |
| Portielje, JE | 1 |
| Liefers, GJ | 1 |
| Bazuro, GE | 1 |
| Torino, F | 1 |
| Gasparini, G | 1 |
| Capurso, L | 1 |
| Zilli, M | 1 |
| Iacobelli, S | 1 |
| Jankowska, H | 1 |
| Hooper, P | 1 |
| Jankowski, JA | 1 |
| Bruno, A | 1 |
| Dovizio, M | 1 |
| Tacconelli, S | 1 |
| Patrignani, P | 1 |
| Beck, PL | 1 |
| Aspinall, AI | 1 |
| Kilvert, VM | 1 |
| Dort, J | 1 |
| Gardiner, PS | 1 |
| Gilmer, JF | 1 |
| Thomson, AB | 1 |
| Barkun, AN | 1 |
| Armstrong, D | 1 |
| Chiba, N | 1 |
| White, RJ | 1 |
| Daniels, S | 1 |
| Escobedo, S | 1 |
| Chakraborty, B | 1 |
| Sinclair, P | 1 |
| Van Zanten, SJ | 1 |
| Wei, WQ | 1 |
| Qiao, YL | 1 |
| Williams, JL | 1 |
| Kashfi, K | 1 |
| Ouyang, N | 1 |
| del Soldato, P | 1 |
| Kopelovich, L | 1 |
| Rigas, B | 1 |
| James, MW | 1 |
| Chen, CM | 1 |
| Goddard, WP | 1 |
| Scott, BB | 1 |
| Goddard, AF | 1 |
| Baenkler, HW | 1 |
| Schäfer, D | 1 |
| Vogt, W | 1 |
| Becker, JC | 1 |
| Domschke, W | 1 |
| Pohle, T | 1 |
| Pacchiarini, L | 1 |
| Serra, L | 1 |
| Grignani, G | 1 |
| Gamba, G | 1 |
| Gorini, M | 1 |
| Thun, MJ | 2 |
| Heath, CW | 2 |
| Luk, GD | 1 |
| Folwaczny, C | 1 |
| Lorenz, R | 1 |
| Loeschke, K | 1 |
| Azarschab, P | 1 |
| Al-Azzeh, E | 1 |
| Kornberger, W | 1 |
| Gött, P | 1 |
| Jolly, K | 1 |
| Cheng, KK | 1 |
| Langman, MJ | 1 |
| Sherlock, P | 1 |
| Shils, ME | 1 |
| Lipkin, M | 1 |
| Winawer, SJ | 1 |
| Baccaro, JC | 1 |
| González, BA | 1 |
| Cupula, CA | 1 |
| Hofhuis, WJ | 1 |
| Oranje, AP | 1 |
| Bouquet, J | 1 |
| Sinaasappel, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Usefulness of Fecal Immunochemical Test in the Diagnosis Algorithm of Iron Deficiency Anemia.[NCT02792023] | 550 participants (Anticipated) | Interventional | 2016-06-30 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
20 reviews available for aspirin and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
Cyclooxygenase Inhibitors and Cancer: The Missing Pieces.
Topics: Aspirin; Carcinogenesis; Colorectal Neoplasms; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 | 2023 |
Aspirin and the risk of colorectal and other digestive tract cancers: an updated meta-analysis through 2019.
Topics: Aspirin; Cohort Studies; Colorectal Neoplasms; Gastrointestinal Neoplasms; Humans | 2020 |
[Effect of aspirin on hepatocellular carcinoma and its related mechanism].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinoma, Hepatocellular; Gastrointestinal Neopla | 2020 |
Continued use of low-dose aspirin may increase risk of bleeding after gastrointestinal endoscopic submucosal dissection: A meta-analysis.
Topics: Anticoagulants; Aspirin; Endoscopic Mucosal Resection; Gastrointestinal Neoplasms; Humans; Platelet | 2017 |
Aspirin in gastrointestinal oncology: new data on an old friend.
Topics: Antineoplastic Agents; Aspirin; Gastrointestinal Neoplasms; Humans; Neoplasm Metastasis; Platelet Ag | 2014 |
Aspirin Use on Incidence and Mortality of Gastrointestinal Cancers: Current State of Epidemiological Evidence.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Colorectal Neopl | 2015 |
Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer.
Topics: Adult; Aged; Aspirin; Colorectal Neoplasms; Female; Follow-Up Studies; Gastrointestinal Neoplasms; H | 2016 |
Bleeding after endoscopic submucosal dissection: Risk factors and preventive methods.
Topics: Anticoagulants; Aspirin; Comorbidity; Endoscopic Mucosal Resection; Endoscopy, Gastrointestinal; Gas | 2016 |
Chemoprevention in gastrointestinal adenocarcinoma: for few but not for all?
Topics: Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colorectal Neoplasms; ErbB Recepto | 2008 |
Chemoprophylaxis in gastrointestinal tumors.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Cyclooxygenase 2 Inhibitors | 2010 |
Aspirin chemoprevention of gastrointestinal cancer in the next decade. A review of the evidence.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chemoprevention; Gastrointestinal Neoplasms; Human | 2010 |
Mechanisms of the antitumoural effects of aspirin in the gastrointestinal tract.
Topics: Adenoma; Anticarcinogenic Agents; Aspirin; Blood Platelets; Cyclooxygenase 1; Cyclooxygenase 2; Cycl | 2012 |
The medicinal chemistry implications of the anticancer effects of aspirin and other NSAIDs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Cyclooxygenase 2; Gastrointestinal Neop | 2003 |
[Non-steroidal anti-inflammatory drugs and chemoprevention of digestive cancer].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chemoprevention; Cyclooxygenase 2; Gastro | 2001 |
[Gastroenterology in the elderly].
Topics: Abdominal Pain; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents, N | 2005 |
[Medicinal prevention of gastrointestinal tumors: aspirin, Helicobacter and more?].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibitors; Gastritis; Gastrointest | 2006 |
Aspirin use and reduced risk of gastrointestinal tract cancers in the American Cancer Society prospective studies.
Topics: American Cancer Society; Aspirin; Data Interpretation, Statistical; Female; Gastrointestinal Neoplas | 1995 |
Prevention of gastrointestinal cancer--the potential role of NSAIDs in colorectal cancer.
Topics: Adenomatous Polyposis Coli; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; | 1996 |
Aspirin and gastrointestinal cancer.
Topics: Adenoma; Adenomatous Polyposis Coli; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinoge | 1997 |
NSAIDs and gastrointestinal cancer prevention.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Case-Control Stu | 2002 |
1 trial available for aspirin and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
Analysis of Body Mass Index in Early and Middle Adulthood and Estimated Risk of Gastrointestinal Cancer.
Topics: Adult; Aspirin; Body Mass Index; Colorectal Neoplasms; Female; Gastrointestinal Neoplasms; Humans; M | 2023 |
28 other studies available for aspirin and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
Safety and effectiveness of low-dose aspirin for the prevention of gastrointestinal cancer in adults without atherosclerotic cardiovascular disease: a population-based cohort study.
Topics: Adult; Aspirin; Cardiovascular Diseases; Cohort Studies; Gastrointestinal Hemorrhage; Gastrointestin | 2022 |
Role of Aspirin in Gastric Cancer Prevention.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 2; Female; Gastrointestinal Neoplas | 2022 |
Effects of low-dose aspirin on clinical outcome and disease progression in patients with gastroenteropancreatic neuroendocrine neoplasm.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Cardiovascular Diseases; Disease Progression; F | 2019 |
[Status of non-steroidal anti-inflammatory drugs use in areas with a high incidence of upper gastrointestinal cancer in China: a multi-center cross-sectional survey].
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; China; Cross | 2019 |
Aspirin to prevent gastrointestinal cancer - but recent trial data do not fit.
Topics: Aspirin; Colorectal Neoplasms; Gastrointestinal Hemorrhage; Gastrointestinal Neoplasms; Humans | 2020 |
Reply to the Letter to the Editor 'Aspirin to prevent gastrointestinal cancer - but recent trial data don't fit' by Jacobsen and colleagues.
Topics: Aspirin; Colorectal Neoplasms; Gastrointestinal Neoplasms; Humans | 2020 |
Effect of Antithrombotic Therapy and Long Endoscopic Submucosal Dissection Procedure Time on Early and Delayed Postoperative Bleeding.
Topics: Aged; Aspirin; Endoscopic Mucosal Resection; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; Ga | 2017 |
Maintenance use of non-steroidal anti-inflammatory drugs and risk of gastrointestinal cancer in a nationwide population-based cohort study in Sweden.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chemoprevention; Cohort Studies; Cycl | 2018 |
[Advances in the prevention of digestive tract tumors by aspirin].
Topics: Aspirin; Gastrointestinal Neoplasms; Humans | 2019 |
Gastrointestinal adverse events after dual antiplatelet therapy: clopidogrel is safer than ticagrelor, but prasugrel data are lacking or inconclusive.
Topics: Acute Coronary Syndrome; Adenosine; Aspirin; Chemical and Drug Induced Liver Injury; Clinical Trials | 2013 |
Aspirin and non-steroidal anti-inflammatory drug use and the risk of upper aerodigestive tract cancer.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Con | 2014 |
On Trial: Evidence From Using Aspirin to Prevent Cancer.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Clinical Trials as | 2015 |
Genomic Profiling in Gastrointestinal Cancer: Are We Ready To Use These Data to Make Treatment Decisions?
Topics: Aspirin; Biomarkers, Tumor; Colorectal Neoplasms; Databases, Genetic; Drug Resistance, Neoplasm; Gas | 2015 |
Aspirin Post-Diagnosis for Gastrointestinal Cancer Linked to Improved Survival.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Gastrointestinal Neoplasms; Humans; Netherlands; S | 2016 |
Aspirin for Cancer Prevention: One Step Closer.
Topics: Aspirin; Colorectal Neoplasms; Gastrointestinal Neoplasms; Humans; Risk Assessment | 2016 |
Effect of low-dose aspirin use on survival of patients with gastrointestinal malignancies; an observational study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Dose-Response Relationship, Drug; Female; Gastr | 2017 |
Blue rubber bleb nevus syndrome.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Celecoxib; Colonic Diseases; Gastrointestina | 2002 |
The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Barret | 2003 |
NO-donating aspirin inhibits intestinal carcinogenesis in Min (APC(Min/+)) mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Body Weight; Cel | 2004 |
Risk factors for gastrointestinal malignancy in patients with iron-deficiency anaemia.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Anti-Inflammatory | 2005 |
Abnormal eicosanoid-pattern of peripheral white-blood cells in gastro-intestinal cancer.
Topics: Adult; Aged; Aged, 80 and over; Arachidonic Acid; Aspirin; Case-Control Studies; Cyclooxygenase Inhi | 2005 |
[In vitro effect of culture fluids from neoplastic tissues on platelet aggregation. I. Human tumors of the gastrointestinal tract].
Topics: Adenosine Diphosphate; Adult; Aspirin; Culture Media; Female; Gastrointestinal Neoplasms; Humans; Ma | 1982 |
Rheumatoid arthritis, aspirin, and gastrointestinal cancer.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Aspirin; Gastrointestinal Neoplasms; | 1993 |
[Does regular administration of aspirin reduce the risk of gastrointestinal carcinomas?].
Topics: Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationship, Drug; | 1996 |
Aspirin promotes TFF2 gene activation in human gastric cancer cell lines.
Topics: Arachidonic Acid; Aspirin; Gastrointestinal Neoplasms; Genes, Reporter; Growth Substances; Humans; I | 2001 |
Effects of cancer treatment on nutrition and gastrointestinal function.
Topics: Antineoplastic Agents; Aspirin; Digestive System; Dose-Response Relationship, Radiation; Gastrointes | 1979 |
[Value of endoscopy in the diagnosis of upper digestive tract hemorrhage].
Topics: Alcoholic Beverages; Aspirin; Critical Care; Duodenal Ulcer; Endoscopy; Esophageal Diseases; Gastroi | 1979 |
Blue rubber-bleb naevus syndrome: report of a case with consumption coagulopathy complicated by manifest thrombosis.
Topics: Anemia, Hemolytic; Aspirin; Dipyridamole; Disseminated Intravascular Coagulation; Female; Gastrointe | 1990 |